|
1
|
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$66.2M
|
+$21.2M
|
+4,072,226
|
+38%
|
|
|
2
|
Perceptive Advisors
New York
|
$42.3M
|
–
|
–
|
–
|
|
|
3
|
Suvretta Capital Management
New York
|
$41.2M
|
+$21.2M
|
+4,069,752
|
+80%
|
|
|
4
|
Wellington Management Group
Boston,
Massachusetts
|
$38.7M
|
-$9.57M
|
-1,834,324
|
-18%
|
|
|
5
|
Baker Bros. Advisors
New York
|
$32.8M
|
–
|
–
|
–
|
|
|
6
|
Vestal Point Capital
New York
|
$32.4M
|
+$4.79M
|
+917,700
|
+15%
|
|
|
7
|
|
$31.2M
|
+$1.93M
|
+368,970
|
+6%
|
|
|
8
|
|
$14M
|
+$3.42M
|
+655,568
|
+27%
|
|
|
9
|
|
$13.9M
|
–
|
–
|
–
|
|
|
10
|
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
$13.4M
|
+$15.5M
|
+2,973,032
|
New
|
|
|
11
|
|
$8.96M
|
-$2.05M
|
-393,114
|
-17%
|
|
|
12
|
Paradigm Biocapital Advisors
New York
|
$8.6M
|
-$18.3M
|
-3,507,301
|
-65%
|
|
|
13
|
RA Capital Management
Boston,
Massachusetts
|
$7.89M
|
–
|
–
|
–
|
|
|
14
|
Woodline Partners
San Francisco,
California
|
$7.6M
|
-$1.83M
|
-349,939
|
-17%
|
|
|
15
|
Sofinnova Investments
Menlo Park,
California
|
$7.01M
|
+$6.32M
|
+1,211,098
|
+353%
|
|
|
16
|
Frazier Life Sciences Management
Palo Alto,
California
|
$5.63M
|
-$4.7M
|
-900,000
|
-42%
|
|
|
17
|
Sphera Funds Management
Tel Aviv,
Israel
|
$4.15M
|
–
|
–
|
–
|
|
|
18
|
|
$3.42M
|
+$376K
|
+72,152
|
+11%
|
|
|
19
|
Aberdeen Group
Edinburgh,
United Kingdom
|
$3.25M
|
+$1.94M
|
+372,207
|
+107%
|
|
|
20
|
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
$3.15M
|
–
|
–
|
–
|
|
|
21
|
683 Capital Management
New York
|
$2.77M
|
-$183K
|
-35,000
|
-5%
|
|
|
22
|
Wasatch Advisors
Salt Lake City,
Utah
|
$2.61M
|
-$1.98M
|
-379,389
|
-40%
|
|
|
23
|
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$2.16M
|
+$1.53M
|
+293,125
|
+158%
|
|
|
24
|
Schroder Investment Management Group
London,
United Kingdom
|
$1.98M
|
–
|
–
|
–
|
|
|
25
|
Platinum Investment Management
Sydney Australia 2000,
Australia
|
$1.41M
|
–
|
–
|
–
|
|
